US FDA approves Moderna's an mRNA respiratory syncytial virus vaccine, mRESVIA
Moderna, Inc. announced that the US Food and Drug Administration (FDA) has approved mRESVIA (mRNA-1345), an mRNA respiratory syncytial virus (RSV) vaccine, to protect adults aged 60 years and older from lower respiratory tract disease caused by RSV …